What does PHARMACIE DUBUISSON do?

PHARMACIE DUBUISSON is a pharmacy in Welkenraedt. Private Limited, started on 17 December 2012, 1 establishment.

What is the address of PHARMACIE DUBUISSON?

The registered office of PHARMACIE DUBUISSON is located at Place des Combattants 19, 4840 Welkenraedt.

Is PHARMACIE DUBUISSON still active?

Yes. According to the CBE (31 October 2026) PHARMACIE DUBUISSON is active, legal situation “Normale toestand”, started on 17 December 2012.

Is PHARMACIE DUBUISSON registered on Peppol?

Yes, PHARMACIE DUBUISSON is registered on the Peppol network with ID 0208:0508493004.

What is the enterprise number of PHARMACIE DUBUISSON?

The enterprise number of PHARMACIE DUBUISSON is BE0508493004.

When was PHARMACIE DUBUISSON founded?

PHARMACIE DUBUISSON was founded on 17 December 2012.

Who are the directors of PHARMACIE DUBUISSON?

According to the 2025 annual accounts, the directors of PHARMACIE DUBUISSON are: Laurence DUBUISSON.

Is PHARMACIE DUBUISSON a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DUBUISSON make in 2025?

PHARMACIE DUBUISSON posted a profit after taxes of € 86,387 in financial year 2025.

What is the revenue of PHARMACIE DUBUISSON?

As a small company, PHARMACIE DUBUISSON is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 164,872.

How many employees does PHARMACIE DUBUISSON have?

According to the 2025 annual accounts, PHARMACIE DUBUISSON has 0.6 full-time equivalents (FTE).

PHARMACIE DUBUISSON (Private Limited) - Welkenraedt

Dossier PHARMACIE DUBUISSON, printed on 31 October 2026 from databakkes.be/en/0508493004/pharmacie-dubuisson. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DUBUISSON from Welkenraedt, company number BE0508493004, closed financial year 2025 with a result of € 86,387 after tax. For that financial year PHARMACIE DUBUISSON recorded a gross margin of € 164,872 and equity of € 398,417. Compared with financial year 2024, the result moved from € 80,043 to € 86,387. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 398,417

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,387

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 471,832

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 49,666 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 27,716

▲ 5% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,528

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 5,000

▼ 83% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 55,112

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 23,005

▼ 26% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 140,980 Gross margin 2022: € 140,980 First fiscal year in the series	€ 148,084 Gross margin 2023: € 148,084 ▲ 5% vs 2022 (€ 140,980) Favourable step	€ 157,592 Gross margin 2024: € 157,592 ▲ 6% vs 2023 (€ 148,084) Favourable step	€ 164,872 Gross margin 2025: € 164,872 ▲ 5% vs 2024 (€ 157,592) Favourable step	▲ 5%
Profit after taxes	€ 51,226 Profit after taxes 2022: € 51,226 First fiscal year in the series	€ 72,262 Profit after taxes 2023: € 72,262 ▲ 41% vs 2022 (€ 51,226) Favourable step	€ 80,043 Profit after taxes 2024: € 80,043 ▲ 11% vs 2023 (€ 72,262) Favourable step	€ 86,387 Profit after taxes 2025: € 86,387 ▲ 8% vs 2024 (€ 80,043) Favourable step	▲ 8%
Equity	€ 285,723 Equity 2022: € 285,723 First fiscal year in the series	€ 337,319 Equity 2023: € 337,319 ▲ 18% vs 2022 (€ 285,723) Favourable step	€ 361,696 Equity 2024: € 361,696 ▲ 7% vs 2023 (€ 337,319) Favourable step	€ 398,417 Equity 2025: € 398,417 ▲ 10% vs 2024 (€ 361,696) Favourable step	▲ 10%
Total debts	€ 181,280 Total debts 2022: € 181,280 First fiscal year in the series	€ 168,342 Total debts 2023: € 168,342 ▼ 7% vs 2022 (€ 181,280) Favourable step	€ 223,320 Total debts 2024: € 223,320 ▲ 33% vs 2023 (€ 168,342) Unfavourable step	€ 192,035 Total debts 2025: € 192,035 ▼ 14% vs 2024 (€ 223,320) Favourable step	▼ 14%
Cash	€ 336,747 Cash 2022: € 336,747 First fiscal year in the series	€ 384,535 Cash 2023: € 384,535 ▲ 14% vs 2022 (€ 336,747) Favourable step	€ 460,843 Cash 2024: € 460,843 ▲ 20% vs 2023 (€ 384,535) Favourable step	€ 471,832 Cash 2025: € 471,832 ▲ 2% vs 2024 (€ 460,843) Favourable step	▲ 2%
Retained profit	€ 265,723 Retained profit 2022: € 265,723 First fiscal year in the series	€ 317,319 Retained profit 2023: € 317,319 ▲ 19% vs 2022 (€ 265,723) Favourable step	€ 341,696 Retained profit 2024: € 341,696 ▲ 8% vs 2023 (€ 317,319) Favourable step	€ 378,417 Retained profit 2025: € 378,417 ▲ 11% vs 2024 (€ 341,696) Favourable step	▲ 11%
Dividend	€ 28,400 Dividend 2022: € 28,400 First fiscal year in the series	€ 20,666 Dividend 2023: € 20,666 ▼ 27% vs 2022 (€ 28,400) Unchanged	€ 55,666 Dividend 2024: € 55,666 ▲ 169% vs 2023 (€ 20,666) Unchanged	€ 49,666 Dividend 2025: € 49,666 ▼ 11% vs 2024 (€ 55,666) Unchanged	▼ 11%
Bank debt	€ 1,667 Bank debt 2022: € 1,667 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 1,667) Favourable step	€ 30,000 Bank debt 2024: € 30,000 Unchanged (€ 0) Unfavourable step	€ 5,000 Bank debt 2025: € 5,000 ▼ 83% vs 2024 (€ 30,000) Favourable step	▼ 83%
Balance sheet total	€ 467,003 Balance sheet total 2022: € 467,003 First fiscal year in the series	€ 505,661 Balance sheet total 2023: € 505,661 ▲ 8% vs 2022 (€ 467,003) Unchanged	€ 585,015 Balance sheet total 2024: € 585,015 ▲ 16% vs 2023 (€ 505,661) Unchanged	€ 590,452 Balance sheet total 2025: € 590,452 ▲ 1% vs 2024 (€ 585,015) Unchanged	▲ 1%
Employees (FTE)	-	0.7 Employees (FTE) 2023: 0.7 First fiscal year in the series	0.6 Employees (FTE) 2024: 0.6 ▼ 0.1 vs 2023 (0.7) Unchanged	0.6 Employees (FTE) 2025: 0.6 Unchanged (0.6) Unchanged

Key figures of PHARMACIE DUBUISSON, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DUBUISSON?

What happened at PHARMACIE DUBUISSON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 86,387 (▲ 8% vs 2024). Source: NBB ↗
Jan 1, 2013 New establishment in Lontzen. KBO
Dec 17, 2012 Start of the company according to the CBE. KBO

In short

From € 51,226 profit in 2022 to € 86,387 profit in 2025.

Paid € 115,179 in corporate taxes since 2022.

Best year ever: 2025, with € 86,387 profit.

Paid out € 154,398 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Laurence DUBUISSON

PHARMACIE DUBUISSON

Behind PHARMACIE DUBUISSON is Laurence DUBUISSON.

Directors

According to the 2025 annual accounts

Laurence DUBUISSON

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Place des Combattants 19

4840 Welkenraedt

2.215.037.065

Rue Mitoyenne 52

4710 Lontzen

Active since 1 January 2013

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PHARMACIE P.P. DARDENNE

€ 391,317 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0508.493.004

VAT number

BE 0508.493.004

Registered office

Place des Combattants 19, 4840 Welkenraedt

Names & denominations

PHARMACIE DUBUISSON

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 December 2012

Peppol

Active · Active since 19 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DUBUISSON

Financials

What happened to PHARMACIE DUBUISSON?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions